Morningstar

Fidelity Select Health Care Portfolio FSPHX

Morningstar Medalist Rating
Medalist Rating as of | See Fidelity Investment Hub
  • NAV / 1-Day Return 27.89  /  −1.83 %
  • Total Assets 6.4B
  • Adj. Expense Ratio
    0.620%
  • Expense Ratio 0.620%
  • Distribution Fee Level Low
  • Share Class Type No Load
  • Category Health
  • Investment Style Mid Blend
  • Min. Initial Investment 0
  • Status Open
  • TTM Yield 0.41%
  • Turnover 69%

USD | NAV as of Jul 20, 2026 | 1-Day Return as of Jul 20, 2026, 9:18 PM GMT+0

Morningstar’s Analysis FSPHX

Will FSPHX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable FSPHX’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the FSPHX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of FSPHX’s parent organization’s priorities and whether they’re in line with investors’ interests.

Still an exceptional source of healthcare exposure for the long term.

Senior Analyst William Samuel Rocco

William Samuel Rocco

Senior Analyst

Summary

Fidelity Health Care Sector remains in the hands of a topnotch team that employs a sound and differentiated approach. The strategy, which includes two mutual funds, retains its High People and Above Average Process ratings.

by William Samuel Rocco
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings FSPHX

More FSPHX Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 38.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

8.03 464M
Healthcare

Danaher Corp

6.89 398M
Healthcare

Johnson & Johnson

4.91 284M
Healthcare

Thermo Fisher Scientific Inc

4.33 250M
Healthcare

UnitedHealth Group Inc

3.49 202M
Healthcare

Alnylam Pharmaceuticals Inc

2.40 139M
Healthcare

Gilead Sciences Inc

2.21 128M
Healthcare

Boston Scientific Corp

2.17 126M
Healthcare

Ascendis Pharma AS

2.17 126M
Healthcare

AbbVie Inc

2.03 118M
Healthcare

Sponsor Center